OTC Marketing Awards 2023: What The Judges Said About The Leading Entries

The trophies have been presented at the OTC Marketing Awards 2023 - but what did the judging panel have to say about the winning and highly-commended entries?

OTC Marketing Award Winners 2023 • Source: Philippa Gedge

Consumer health companies and their agencies have been recognized for their achievements over the past year at the OTC Marketing Awards 2023.

More from Innovation & IP

Bayer Acquires Cara Care Digestive Health App To Grow Precision Health Business

 
• By 

Bayer Consumer Health snaps up digital therapeutic Cara Care for its Precision Health business with an eye to developing its self-care capabilities.

Bayer Drops Plan For EU OTC Antifungal Launch After Poor Trial Results

 
• By 

Bayer Consumer Health shelves European launch of topical OTC onychomycosis treatment under its Canesten brand after a Phase III trial of the product - developed by Sweden's Moberg Pharma - failed to meet its primary endpoint.

Opella Crowned Company Of The Year At OTC Marketing Awards 2024

 
• By 

Winners across 12 categories were announced at the OTC Marketing Awards 2024 on 21 November, with Opella taking the top prize as OTC Company of the Year.

Denmark Switches Nalxone To OTC Status

 
• By 

Consumers in Denmark no longer need a prescription to buy opioid antagonist naloxone as the country looks to tackle the growing issue of overdose.

More from Health

Ad Claims Relying On Product Test Questionnaires Must Reflect Wording – NAD

 

Anti-aging skin care device marketer UVVU Inc. agreed to discontinue or modify a number of claims for its SolaWave 4-in-1 Skin Care Wand with Red Light Therapy, since statements were not substantiated by an in-home use study on which they relied, says the National Advertising Division.

People On The Move: Appointments At Maxwellia, Reckitt, Barentz

 
• By 

A round-up of the latest European consumer health appointments: Maxwellia adds CFO and board member; Reckitt restructures operations; Barentz names CEO.

Statin In Technology-Assisted OTC Study May Be First To Take ‘Fail-First’ Step For ‘ACNU’ Switch

 

Study completed in 2024 showed consumers using an online application accurately self-selected and safely used an Rx statin drug. An “ACNU” switch NDA would have to first show conventional OTC labeling won’t support proper self-selection and use.